MSL
BIIB icon

Mackay Shields LLC’s Biogen BIIB Stock Holding History

Mackay Shields LLC’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-21,286
Closed -$4.48M – 299
2022
Q1 		$4.48M Sell
21,286
-830
-4% -$180K 0.04% 382
2021
Q4 		$5.31M Sell
22,116
-822
-4% -$211K 0.04% 356
2021
Q3 		$6.49M Sell
22,938
-1,089
-5% -$357K 0.06% 280
2021
Q2 		$8.32M Sell
24,027
-32,490
-57% -$9.84M 0.08% 241
2021
Q1 		$15.8M Sell
56,517
-39,587
-41% -$10.7M 0.12% 189
2020
Q4 		$23.5M Buy
96,104
+5,933
+7% +$1.53M 0.16% 141
2020
Q3 		$25.6M Sell
90,171
-701
-0.8% -$196K 0.17% 119
2020
Q2 		$24.3M Buy
90,872
+7,109
+8% +$2.14M 0.19% 120
2020
Q1 		$26.5M Sell
83,763
-20,715
-20% -$6.29M 0.25% 88
2019
Q4 		$31M Buy
104,478
+27,193
+35% +$7.54M 0.21% 112
2019
Q3 		$18M Sell
77,285
-27,300
-26% -$6.36M 0.11% 215
2019
Q2 		$24.5M Buy
104,585
+1,416
+1% +$327K 0.17% 128
2019
Q1 		$24.4M Buy
103,169
+8,317
+9% +$2.62M 0.18% 128
2018
Q4 		$28.5M Sell
94,852
-3,538
-4% -$1.13M 0.23% 88
2018
Q3 		$34.8M Buy
98,390
+46,136
+88% +$15.9M 0.27% 93
2018
Q2 		$15.2M Sell
52,254
-14,448
-22% -$4.06M 0.11% 246
2018
Q1 		$18.3M Buy
+66,702
New +$20.7M 0.11% 223

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Mackay Shields LLC's BIIB Position: Q2 2022 in Review

Mackay Shields LLC sold out of Biogen (BIIB) in Q2 2022, closing a stake of 21,286 shares — an estimated $4.48M sold.

Mackay Shields LLC first reported a position in BIIB in Q1 2018 and held it in 17 quarters. The position peaked at $34.8M in Q3 2018. 927 funds tracked by Wall St. Rank hold BIIB as of Q2 2022.

  • Mackay Shields LLC reported no remaining Biogen position as of Q2 2022 after selling out during the quarter.
  • Mackay Shields LLC sold 21,286 Biogen shares in Q2 2022, an estimated $4.48M.
  • Mackay Shields LLC first reported a position in Biogen in Q1 2018 and held it in 17 quarters.
  • Mackay Shields LLC's Biogen position peaked at $34.8M in Q3 2018.
  • 927 funds tracked by Wall St. Rank held Biogen as of Q2 2022.

Based on Mackay Shields LLC's 13F filing for Q2 2022, filed 3 Aug 2022.